|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from Operating Activities | |||||
| Net loss | |||||
| Fair value of vested options and warrants | |||||
| Stock-based compensation expense – warrant modification | |||||
| Fair value of common stock issued for services | |||||
| Issuance of common stock as compensation | |||||
| Amortization of debt discount | |||||
| Accrued interest expense | |||||
| Gain on partial forgiveness of PPP note payable | |||||
| Accrued interest | |||||
| Depreciation | |||||
| Changes in operating assets and liabilities: | |||||
| Operating lease right of use asset | |||||
| Prepaid expenses and other current assets | |||||
| Prepaid expenses | |||||
| Accounts payable and accrued expenses | |||||
| Accounts payable – license agreements | |||||
| Operating lease liabilities | |||||
| Net cash used in operating activities | |||||
| Purchase of property and equipment | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities | |||||
| Net proceeds from issuance of convertible notes and warrants | |||||
| Net proceeds from exercise of warrants and options | |||||
| Principal payment on PPP loan payable | |||||
| Net cash provided by financing activities | |||||
| Net increase (decrease) in cash | |||||
| Cash, beginning of period | |||||
| Cash, end of period | |||||
| Supplemental disclosures of cash flow information | |||||
| Interest | |||||
| Income Taxes | |||||
| Non-cash investing and financing activities | |||||
| Conversion of convertible notes to common stock, net | |||||
| Cashless exercise of warrants applied to settlement of accounts payable | |||||
| Common stock issued for settlement of accounts payable | |||||
| Relative fair value of warrants associated with issued convertible notes | |||||
Loading...